CN102988703A - 一种治疗肾阳虚的中药制剂及其制备方法 - Google Patents
一种治疗肾阳虚的中药制剂及其制备方法 Download PDFInfo
- Publication number
- CN102988703A CN102988703A CN201210583057XA CN201210583057A CN102988703A CN 102988703 A CN102988703 A CN 102988703A CN 201210583057X A CN201210583057X A CN 201210583057XA CN 201210583057 A CN201210583057 A CN 201210583057A CN 102988703 A CN102988703 A CN 102988703A
- Authority
- CN
- China
- Prior art keywords
- parts
- kidney
- yang
- fructus
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 149
- 238000002360 preparation method Methods 0.000 title claims abstract description 56
- 208000031975 Yang Deficiency Diseases 0.000 title abstract description 24
- 210000000582 semen Anatomy 0.000 claims abstract description 17
- 229940079593 drug Drugs 0.000 claims description 65
- 238000011282 treatment Methods 0.000 claims description 42
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 28
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 24
- 239000000843 powder Substances 0.000 claims description 22
- 241000756943 Codonopsis Species 0.000 claims description 18
- 238000010438 heat treatment Methods 0.000 claims description 18
- 239000000706 filtrate Substances 0.000 claims description 17
- 239000000243 solution Substances 0.000 claims description 17
- 240000006108 Allium ampeloprasum Species 0.000 claims description 16
- 235000005254 Allium ampeloprasum Nutrition 0.000 claims description 16
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 16
- 238000000605 extraction Methods 0.000 claims description 15
- 239000002994 raw material Substances 0.000 claims description 12
- 238000010992 reflux Methods 0.000 claims description 12
- 239000002775 capsule Substances 0.000 claims description 11
- 239000003826 tablet Substances 0.000 claims description 11
- 241001446509 Psoralea Species 0.000 claims description 8
- 239000002552 dosage form Substances 0.000 claims description 7
- 238000002481 ethanol extraction Methods 0.000 claims description 6
- 239000007921 spray Substances 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 5
- 239000008187 granular material Substances 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 5
- 239000013618 particulate matter Substances 0.000 claims description 5
- 230000002829 reductive effect Effects 0.000 claims description 5
- 238000007873 sieving Methods 0.000 claims description 5
- 238000001694 spray drying Methods 0.000 claims description 5
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 239000006187 pill Substances 0.000 claims description 4
- 229920002472 Starch Polymers 0.000 claims description 3
- 238000010410 dusting Methods 0.000 claims description 3
- 235000012907 honey Nutrition 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 235000019698 starch Nutrition 0.000 claims description 3
- 239000008107 starch Substances 0.000 claims description 3
- 238000000748 compression moulding Methods 0.000 claims description 2
- 230000006837 decompression Effects 0.000 claims description 2
- 239000008298 dragée Substances 0.000 claims description 2
- 239000002662 enteric coated tablet Substances 0.000 claims description 2
- 239000007941 film coated tablet Substances 0.000 claims description 2
- 238000000227 grinding Methods 0.000 claims description 2
- 239000007902 hard capsule Substances 0.000 claims description 2
- 239000007924 injection Substances 0.000 claims description 2
- 238000002347 injection Methods 0.000 claims description 2
- 239000011505 plaster Substances 0.000 claims description 2
- 238000004064 recycling Methods 0.000 claims description 2
- 239000007901 soft capsule Substances 0.000 claims description 2
- -1 sublimed preparation Substances 0.000 claims description 2
- 239000007940 sugar coated tablet Substances 0.000 claims description 2
- 239000000829 suppository Substances 0.000 claims description 2
- 239000006188 syrup Substances 0.000 claims description 2
- 235000020357 syrup Nutrition 0.000 claims description 2
- 210000003734 kidney Anatomy 0.000 abstract description 132
- 230000007812 deficiency Effects 0.000 abstract description 71
- 239000008280 blood Substances 0.000 abstract description 50
- 210000004369 blood Anatomy 0.000 abstract description 48
- 230000000694 effects Effects 0.000 abstract description 38
- 210000000988 bone and bone Anatomy 0.000 abstract description 28
- 210000003205 muscle Anatomy 0.000 abstract description 24
- 201000001881 impotence Diseases 0.000 abstract description 20
- 208000024891 symptom Diseases 0.000 abstract description 17
- 239000000463 material Substances 0.000 abstract description 14
- 208000002173 dizziness Diseases 0.000 abstract description 12
- 230000008901 benefit Effects 0.000 abstract description 10
- 206010036596 premature ejaculation Diseases 0.000 abstract description 9
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 abstract description 7
- 208000000509 infertility Diseases 0.000 abstract description 5
- 230000036512 infertility Effects 0.000 abstract description 5
- 231100000535 infertility Toxicity 0.000 abstract description 5
- 241000209020 Cornus Species 0.000 abstract description 3
- 244000003377 Allium tuberosum Species 0.000 abstract description 2
- 235000005338 Allium tuberosum Nutrition 0.000 abstract description 2
- 235000015096 spirit Nutrition 0.000 abstract description 2
- 235000019640 taste Nutrition 0.000 abstract description 2
- 241000427159 Achyranthes Species 0.000 abstract 1
- 235000018645 Allium odorum Nutrition 0.000 abstract 1
- 241000007126 Codonopsis pilosula Species 0.000 abstract 1
- 241001116742 Drynaria Species 0.000 abstract 1
- 206010016326 Feeling cold Diseases 0.000 abstract 1
- 244000241838 Lycium barbarum Species 0.000 abstract 1
- 235000015459 Lycium barbarum Nutrition 0.000 abstract 1
- 235000015468 Lycium chinense Nutrition 0.000 abstract 1
- 241000263340 Orobanche coerulescens Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- 240000007651 Rubus glaucus Species 0.000 abstract 1
- 235000011034 Rubus glaucus Nutrition 0.000 abstract 1
- 235000009122 Rubus idaeus Nutrition 0.000 abstract 1
- 235000008422 Schisandra chinensis Nutrition 0.000 abstract 1
- 240000006079 Schisandra chinensis Species 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 230000007721 medicinal effect Effects 0.000 abstract 1
- 210000004291 uterus Anatomy 0.000 abstract 1
- 241000699670 Mus sp. Species 0.000 description 42
- 210000001624 hip Anatomy 0.000 description 28
- 208000002193 Pain Diseases 0.000 description 27
- 241001465754 Metazoa Species 0.000 description 24
- 239000007789 gas Substances 0.000 description 24
- 210000004185 liver Anatomy 0.000 description 23
- 230000006870 function Effects 0.000 description 20
- 238000000034 method Methods 0.000 description 20
- 238000012360 testing method Methods 0.000 description 20
- 201000010099 disease Diseases 0.000 description 19
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 19
- 101800000414 Corticotropin Proteins 0.000 description 17
- 239000000055 Corticotropin-Releasing Hormone Substances 0.000 description 17
- IDLFZVILOHSSID-OVLDLUHVSA-N corticotropin Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)NC(=O)[C@@H](N)CO)C1=CC=C(O)C=C1 IDLFZVILOHSSID-OVLDLUHVSA-N 0.000 description 17
- 229960000258 corticotropin Drugs 0.000 description 17
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 16
- 238000005728 strengthening Methods 0.000 description 15
- 206010012735 Diarrhoea Diseases 0.000 description 14
- 230000037396 body weight Effects 0.000 description 14
- 210000002966 serum Anatomy 0.000 description 14
- 238000002474 experimental method Methods 0.000 description 13
- 239000008929 jingui shenqi Substances 0.000 description 13
- 210000000952 spleen Anatomy 0.000 description 13
- 230000008569 process Effects 0.000 description 12
- 238000010792 warming Methods 0.000 description 12
- 241000699666 Mus <mouse, genus> Species 0.000 description 11
- 241001508464 Orobanche Species 0.000 description 11
- 230000000857 drug effect Effects 0.000 description 11
- 230000001737 promoting effect Effects 0.000 description 11
- 210000003414 extremity Anatomy 0.000 description 10
- 210000004072 lung Anatomy 0.000 description 10
- 230000001717 pathogenic effect Effects 0.000 description 10
- 208000006820 Arthralgia Diseases 0.000 description 9
- 210000000629 knee joint Anatomy 0.000 description 9
- 230000003014 reinforcing effect Effects 0.000 description 9
- 206010011224 Cough Diseases 0.000 description 8
- 208000010228 Erectile Dysfunction Diseases 0.000 description 8
- 206010021118 Hypotonia Diseases 0.000 description 8
- 241000700159 Rattus Species 0.000 description 8
- 208000009205 Tinnitus Diseases 0.000 description 8
- 230000017531 blood circulation Effects 0.000 description 8
- 210000004556 brain Anatomy 0.000 description 8
- 235000009508 confectionery Nutrition 0.000 description 8
- 208000017561 flaccidity Diseases 0.000 description 8
- 210000003127 knee Anatomy 0.000 description 8
- 230000027939 micturition Effects 0.000 description 8
- 244000052769 pathogen Species 0.000 description 8
- 208000011580 syndromic disease Diseases 0.000 description 8
- 229960003604 testosterone Drugs 0.000 description 8
- 230000035922 thirst Effects 0.000 description 8
- 231100000886 tinnitus Toxicity 0.000 description 8
- 206010016256 fatigue Diseases 0.000 description 7
- 230000001568 sexual effect Effects 0.000 description 7
- 230000008093 supporting effect Effects 0.000 description 7
- 230000009182 swimming Effects 0.000 description 7
- 210000001835 viscera Anatomy 0.000 description 7
- 206010059013 Nocturnal emission Diseases 0.000 description 6
- 208000004880 Polyuria Diseases 0.000 description 6
- 206010037660 Pyrexia Diseases 0.000 description 6
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 6
- 208000031971 Yin Deficiency Diseases 0.000 description 6
- 210000001015 abdomen Anatomy 0.000 description 6
- 230000002567 autonomic effect Effects 0.000 description 6
- 230000001276 controlling effect Effects 0.000 description 6
- 230000006735 deficit Effects 0.000 description 6
- 230000035619 diuresis Effects 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 206010022437 insomnia Diseases 0.000 description 6
- 230000004060 metabolic process Effects 0.000 description 6
- 210000003491 skin Anatomy 0.000 description 6
- 230000004083 survival effect Effects 0.000 description 6
- 206010063659 Aversion Diseases 0.000 description 5
- 206010019233 Headaches Diseases 0.000 description 5
- 208000019255 Menstrual disease Diseases 0.000 description 5
- 206010027514 Metrorrhagia Diseases 0.000 description 5
- 208000012886 Vertigo Diseases 0.000 description 5
- 230000008485 antagonism Effects 0.000 description 5
- 230000009286 beneficial effect Effects 0.000 description 5
- 230000006378 damage Effects 0.000 description 5
- 230000034994 death Effects 0.000 description 5
- 239000012153 distilled water Substances 0.000 description 5
- 231100000869 headache Toxicity 0.000 description 5
- 238000002560 therapeutic procedure Methods 0.000 description 5
- 231100000889 vertigo Toxicity 0.000 description 5
- 206010000087 Abdominal pain upper Diseases 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 4
- 208000000059 Dyspnea Diseases 0.000 description 4
- 206010013975 Dyspnoeas Diseases 0.000 description 4
- 208000008967 Enuresis Diseases 0.000 description 4
- 241000201295 Euphrasia Species 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 206010062767 Hypophysitis Diseases 0.000 description 4
- 206010024264 Lethargy Diseases 0.000 description 4
- 206010030113 Oedema Diseases 0.000 description 4
- 206010033557 Palpitations Diseases 0.000 description 4
- 206010047513 Vision blurred Diseases 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 206010003549 asthenia Diseases 0.000 description 4
- 230000033228 biological regulation Effects 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 230000002950 deficient Effects 0.000 description 4
- 230000009977 dual effect Effects 0.000 description 4
- 229940088597 hormone Drugs 0.000 description 4
- 239000005556 hormone Substances 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- 210000002414 leg Anatomy 0.000 description 4
- 210000004698 lymphocyte Anatomy 0.000 description 4
- 239000002398 materia medica Substances 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 210000000056 organ Anatomy 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 230000002035 prolonged effect Effects 0.000 description 4
- 238000010791 quenching Methods 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 230000002269 spontaneous effect Effects 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 208000008035 Back Pain Diseases 0.000 description 3
- 206010010144 Completed suicide Diseases 0.000 description 3
- 206010011878 Deafness Diseases 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- VSNHCAURESNICA-UHFFFAOYSA-N Hydroxyurea Chemical compound NC(=O)NO VSNHCAURESNICA-UHFFFAOYSA-N 0.000 description 3
- 208000008930 Low Back Pain Diseases 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 3
- 210000004404 adrenal cortex Anatomy 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 239000003098 androgen Substances 0.000 description 3
- 208000019902 chronic diarrheal disease Diseases 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 210000002683 foot Anatomy 0.000 description 3
- 238000003304 gavage Methods 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 230000002607 hemopoietic effect Effects 0.000 description 3
- 230000002440 hepatic effect Effects 0.000 description 3
- 229960001330 hydroxycarbamide Drugs 0.000 description 3
- 210000003016 hypothalamus Anatomy 0.000 description 3
- 230000036737 immune function Effects 0.000 description 3
- 208000021267 infertility disease Diseases 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 210000003141 lower extremity Anatomy 0.000 description 3
- 230000003211 malignant effect Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 235000013372 meat Nutrition 0.000 description 3
- 230000002175 menstrual effect Effects 0.000 description 3
- 206010029410 night sweats Diseases 0.000 description 3
- 230000036565 night sweats Effects 0.000 description 3
- 239000013641 positive control Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 230000001256 tonic effect Effects 0.000 description 3
- 210000003932 urinary bladder Anatomy 0.000 description 3
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 241001550206 Colla Species 0.000 description 2
- 206010010356 Congenital anomaly Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 241000134884 Ericales Species 0.000 description 2
- 108010023302 HDL Cholesterol Proteins 0.000 description 2
- 208000031361 Hiccup Diseases 0.000 description 2
- 239000009636 Huang Qi Substances 0.000 description 2
- HLFSDGLLUJUHTE-SNVBAGLBSA-N Levamisole Chemical compound C1([C@H]2CN3CCSC3=N2)=CC=CC=C1 HLFSDGLLUJUHTE-SNVBAGLBSA-N 0.000 description 2
- 206010024419 Libido decreased Diseases 0.000 description 2
- 206010034568 Peripheral coldness Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 206010041497 Spermatorrhoea Diseases 0.000 description 2
- 102000007501 Thymosin Human genes 0.000 description 2
- 108010046075 Thymosin Proteins 0.000 description 2
- 206010046543 Urinary incontinence Diseases 0.000 description 2
- HLXRWTJXGMHOFN-XJSNKYLASA-N Verbenalin Chemical compound O([C@@H]1OC=C([C@H]2C(=O)C[C@H](C)[C@H]21)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HLXRWTJXGMHOFN-XJSNKYLASA-N 0.000 description 2
- 206010047642 Vitiligo Diseases 0.000 description 2
- 230000003187 abdominal effect Effects 0.000 description 2
- 208000004631 alopecia areata Diseases 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 230000027326 copulation Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 238000002651 drug therapy Methods 0.000 description 2
- 206010013781 dry mouth Diseases 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 206010013990 dysuria Diseases 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 229940011871 estrogen Drugs 0.000 description 2
- 239000000262 estrogen Substances 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 230000005714 functional activity Effects 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 238000009499 grossing Methods 0.000 description 2
- 208000023513 hiccough Diseases 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 230000003907 kidney function Effects 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 229960001614 levamisole Drugs 0.000 description 2
- 230000001795 light effect Effects 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 239000012567 medical material Substances 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 206010029446 nocturia Diseases 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 235000011837 pasties Nutrition 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- JVXZRQGOGOXCEC-UHFFFAOYSA-N scutellarein Chemical compound C1=CC(O)=CC=C1C1=CC(=O)C2=C(O)C(O)=C(O)C=C2O1 JVXZRQGOGOXCEC-UHFFFAOYSA-N 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 235000019615 sensations Nutrition 0.000 description 2
- 238000007493 shaping process Methods 0.000 description 2
- 230000035943 smell Effects 0.000 description 2
- 230000021595 spermatogenesis Effects 0.000 description 2
- 239000003270 steroid hormone Substances 0.000 description 2
- 201000009032 substance abuse Diseases 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 238000002636 symptomatic treatment Methods 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- LCJVIYPJPCBWKS-NXPQJCNCSA-N thymosin Chemical compound SC[C@@H](N)C(=O)N[C@H](CO)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CO)C(=O)N[C@H](CO)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@H]([C@H](C)O)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](C(C)C)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@H](CCC(O)=O)C(O)=O LCJVIYPJPCBWKS-NXPQJCNCSA-N 0.000 description 2
- 230000004304 visual acuity Effects 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- VSNHCAURESNICA-NJFSPNSNSA-N 1-oxidanylurea Chemical compound N[14C](=O)NO VSNHCAURESNICA-NJFSPNSNSA-N 0.000 description 1
- ZOOGRGPOEVQQDX-UUOKFMHZSA-N 3',5'-cyclic GMP Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=C(NC2=O)N)=C2N=C1 ZOOGRGPOEVQQDX-UUOKFMHZSA-N 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 244000296912 Ageratum conyzoides Species 0.000 description 1
- 235000004405 Ageratum conyzoides Nutrition 0.000 description 1
- 102000055006 Calcitonin Human genes 0.000 description 1
- 108060001064 Calcitonin Proteins 0.000 description 1
- 235000016535 Capraria biflora Nutrition 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 208000032170 Congenital Abnormalities Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 208000006313 Delayed Hypersensitivity Diseases 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 108090000371 Esterases Proteins 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 206010016825 Flushing Diseases 0.000 description 1
- 206010060891 General symptom Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010010234 HDL Lipoproteins Proteins 0.000 description 1
- 102000015779 HDL Lipoproteins Human genes 0.000 description 1
- 208000008899 Habitual abortion Diseases 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 108010006464 Hemolysin Proteins Proteins 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- STECJAGHUSJQJN-GAUPFVANSA-N Hyoscine Natural products C1([C@H](CO)C(=O)OC2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-GAUPFVANSA-N 0.000 description 1
- 235000017309 Hypericum perforatum Nutrition 0.000 description 1
- 206010021639 Incontinence Diseases 0.000 description 1
- 208000019637 Infantile Diarrhea Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 206010023201 Joint contracture Diseases 0.000 description 1
- YJPIGAIKUZMOQA-UHFFFAOYSA-N Melatonin Natural products COC1=CC=C2N(C(C)=O)C=C(CCN)C2=C1 YJPIGAIKUZMOQA-UHFFFAOYSA-N 0.000 description 1
- 241000157491 Morinda Species 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- STECJAGHUSJQJN-UHFFFAOYSA-N N-Methyl-scopolamin Natural products C1C(C2C3O2)N(C)C3CC1OC(=O)C(CO)C1=CC=CC=C1 STECJAGHUSJQJN-UHFFFAOYSA-N 0.000 description 1
- 108090000189 Neuropeptides Proteins 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 241000222640 Polyporus Species 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 230000002292 Radical scavenging effect Effects 0.000 description 1
- 101500024108 Rattus norvegicus Corticotropin Proteins 0.000 description 1
- 206010062104 Renal mass Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 240000002657 Thymus vulgaris Species 0.000 description 1
- 235000007303 Thymus vulgaris Nutrition 0.000 description 1
- HLXRWTJXGMHOFN-UHFFFAOYSA-N Verbenalin Natural products C12C(C)CC(=O)C2C(C(=O)OC)=COC1OC1OC(CO)C(O)C(O)C1O HLXRWTJXGMHOFN-UHFFFAOYSA-N 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 206010000210 abortion Diseases 0.000 description 1
- 231100000176 abortion Toxicity 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 208000029359 adrenal cortex disease Diseases 0.000 description 1
- 210000004100 adrenal gland Anatomy 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 239000002269 analeptic agent Substances 0.000 description 1
- 230000003555 analeptic effect Effects 0.000 description 1
- 210000003423 ankle Anatomy 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000000680 avirulence Effects 0.000 description 1
- 206010003883 azoospermia Diseases 0.000 description 1
- 238000012742 biochemical analysis Methods 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 238000004820 blood count Methods 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 description 1
- 229960004015 calcitonin Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000015111 chews Nutrition 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 231100000132 chronic toxicity testing Toxicity 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000001427 coherent effect Effects 0.000 description 1
- 230000001447 compensatory effect Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 230000009123 feedback regulation Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 238000002309 gasification Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 210000002149 gonad Anatomy 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 239000003228 hemolysin Substances 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 239000008738 huangbai Substances 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 229940082126 hydroxyurea 300 mg Drugs 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 230000002267 hypothalamic effect Effects 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 238000010166 immunofluorescence Methods 0.000 description 1
- 230000003116 impacting effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 239000010977 jade Substances 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 208000013433 lightheadedness Diseases 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 230000000527 lymphocytic effect Effects 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 229960003987 melatonin Drugs 0.000 description 1
- DRLFMBDRBRZALE-UHFFFAOYSA-N melatonin Chemical compound COC1=CC=C2NC=C(CCNC(C)=O)C2=C1 DRLFMBDRBRZALE-UHFFFAOYSA-N 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 230000001617 migratory effect Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 208000010553 multiple abscesses Diseases 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 235000017524 noni Nutrition 0.000 description 1
- 239000000820 nonprescription drug Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 208000008634 oligospermia Diseases 0.000 description 1
- 230000036616 oligospermia Effects 0.000 description 1
- 231100000528 oligospermia Toxicity 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 210000003024 peritoneal macrophage Anatomy 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000001817 pituitary effect Effects 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 238000011127 radiochemotherapy Methods 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000033458 reproduction Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- STECJAGHUSJQJN-FWXGHANASA-N scopolamine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-FWXGHANASA-N 0.000 description 1
- 229960002646 scopolamine Drugs 0.000 description 1
- 210000002955 secretory cell Anatomy 0.000 description 1
- 230000036299 sexual function Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 230000002992 thymic effect Effects 0.000 description 1
- 239000001585 thymus vulgaris Substances 0.000 description 1
- 230000001971 thyroidal effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 210000001113 umbilicus Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 210000001235 zona fasciculata Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210583057.XA CN102988703B (zh) | 2012-12-27 | 2012-12-27 | 一种治疗肾阳虚的中药制剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210583057.XA CN102988703B (zh) | 2012-12-27 | 2012-12-27 | 一种治疗肾阳虚的中药制剂及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102988703A true CN102988703A (zh) | 2013-03-27 |
CN102988703B CN102988703B (zh) | 2014-09-03 |
Family
ID=47918135
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210583057.XA Expired - Fee Related CN102988703B (zh) | 2012-12-27 | 2012-12-27 | 一种治疗肾阳虚的中药制剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102988703B (zh) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103202937A (zh) * | 2013-04-20 | 2013-07-17 | 上海浦东高星生物技术研究所 | 增精丸 |
CN104147323A (zh) * | 2014-08-28 | 2014-11-19 | 广西梧州三鹤药业有限公司 | 治疗肾阳虚的中药组合物及其制备方法 |
CN104324291A (zh) * | 2014-11-17 | 2015-02-04 | 青岛恒波仪器有限公司 | 一种治疗大肠湿热型便血的中药制剂及其制备方法 |
CN104397284A (zh) * | 2014-11-27 | 2015-03-11 | 青岛申达高新技术开发有限公司 | 一种补肾壮骨的刺五加保健茶及其制备方法 |
CN104435311A (zh) * | 2014-11-12 | 2015-03-25 | 青岛恒波仪器有限公司 | 一种补肾壮骨的菟丝子口服液及其制备方法 |
CN104784546A (zh) * | 2015-04-23 | 2015-07-22 | 青岛市第三人民医院 | 用于防治甲型h1n1流感的药物 |
CN106260832A (zh) * | 2015-05-22 | 2017-01-04 | 张飞 | 一种治肾阳虚所致的夜尿增长、遗尿的食疗配方 |
CN114796196A (zh) * | 2022-06-27 | 2022-07-29 | 山东省中医药研究院 | 一种治疗血管源性眩晕的外用药物组合物及应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1615998A (zh) * | 2004-09-27 | 2005-05-18 | 俞锋 | 一种补肾胶囊及其制备方法 |
CN101485820A (zh) * | 2009-02-10 | 2009-07-22 | 汪维军 | 一种中老年保健丸 |
CN102688431A (zh) * | 2012-06-01 | 2012-09-26 | 湖南省回春堂药业有限公司 | 一种补肾口服液及其制备方法 |
-
2012
- 2012-12-27 CN CN201210583057.XA patent/CN102988703B/zh not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1615998A (zh) * | 2004-09-27 | 2005-05-18 | 俞锋 | 一种补肾胶囊及其制备方法 |
CN101485820A (zh) * | 2009-02-10 | 2009-07-22 | 汪维军 | 一种中老年保健丸 |
CN102688431A (zh) * | 2012-06-01 | 2012-09-26 | 湖南省回春堂药业有限公司 | 一种补肾口服液及其制备方法 |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103202937A (zh) * | 2013-04-20 | 2013-07-17 | 上海浦东高星生物技术研究所 | 增精丸 |
CN104147323A (zh) * | 2014-08-28 | 2014-11-19 | 广西梧州三鹤药业有限公司 | 治疗肾阳虚的中药组合物及其制备方法 |
CN104147323B (zh) * | 2014-08-28 | 2017-07-11 | 广西梧州三鹤药业有限公司 | 治疗肾阳虚的中药组合物及其制备方法 |
CN104435311A (zh) * | 2014-11-12 | 2015-03-25 | 青岛恒波仪器有限公司 | 一种补肾壮骨的菟丝子口服液及其制备方法 |
CN104324291A (zh) * | 2014-11-17 | 2015-02-04 | 青岛恒波仪器有限公司 | 一种治疗大肠湿热型便血的中药制剂及其制备方法 |
CN104397284A (zh) * | 2014-11-27 | 2015-03-11 | 青岛申达高新技术开发有限公司 | 一种补肾壮骨的刺五加保健茶及其制备方法 |
CN104784546A (zh) * | 2015-04-23 | 2015-07-22 | 青岛市第三人民医院 | 用于防治甲型h1n1流感的药物 |
CN106260832A (zh) * | 2015-05-22 | 2017-01-04 | 张飞 | 一种治肾阳虚所致的夜尿增长、遗尿的食疗配方 |
CN114796196A (zh) * | 2022-06-27 | 2022-07-29 | 山东省中医药研究院 | 一种治疗血管源性眩晕的外用药物组合物及应用 |
CN114796196B (zh) * | 2022-06-27 | 2022-09-16 | 山东省中医药研究院 | 一种治疗血管源性眩晕的外用药物组合物及应用 |
Also Published As
Publication number | Publication date |
---|---|
CN102988703B (zh) | 2014-09-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102988703B (zh) | 一种治疗肾阳虚的中药制剂及其制备方法 | |
CN100473413C (zh) | 一种治疗老年期痴呆的中药制剂 | |
CN102078520A (zh) | 一种治疗神经性头痛的中药制剂及其制备方法 | |
CN103041209B (zh) | 一种治疗肾阴虚的中药制剂及其制备方法 | |
CN103800670A (zh) | 一种治疗肾阳虚的中药制剂及其制备方法 | |
CN104367879A (zh) | 一种用于治疗鸡劳伤的药物组合物及其制备方法 | |
CN107126485A (zh) | 一种辅助改善睡眠的中药组合物及其制备方法和应用 | |
CN102846906B (zh) | 一种治疗卵巢早衰的药物及其制备方法 | |
CN104958607A (zh) | 一种治疗妇女更年期灼口综合征的中药组合物及方法 | |
CN104208418A (zh) | 一种固精缩尿补肾的金樱子保健口服液及其制备方法 | |
CN101507776B (zh) | 一种治疗肾虚、腰膝酸软的中药制剂及其制备方法 | |
CN107432881A (zh) | 一种中药组合物、制备方法及其在改善和治疗男性性功能方面的应用 | |
CN104721582A (zh) | 一种治疗肾虚型月经过少的药物及其制备方法 | |
CN103272119A (zh) | 一种用于治疗骨质疏松的中药制剂 | |
CN103285211B (zh) | 一种用于治疗病理肥胖的中药颗粒 | |
CN105796845A (zh) | 药物组合物在制备治疗女性更年期综合征药物中的用途 | |
CN102048913B (zh) | 一种治疗更年期综合症的中药制剂及其制备方法 | |
CN103919961B (zh) | 一种治疗中老年肾亏肾阳虚的中药制剂及其制备方法 | |
CN105362629A (zh) | 一种含有杜仲的治疗女性更年期综合症的药物组合物及其制备方法 | |
CN105194355A (zh) | 一种治疗原发性高血压的中药制剂 | |
CN104906526A (zh) | 一种用于卵巢早衰的中药制剂及其制备方法 | |
CN104324134A (zh) | 一种改善微循环的中药组合物及其制备方法 | |
CN110237161A (zh) | 用于治疗绝经综合征的药物及其制备方法和应用 | |
CN106421099A (zh) | 一种改善男性性功能的药物及其制备方法 | |
CN105194433A (zh) | 一种内科治疗老年体虚症的中药组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: QINGDAO HUAREN TECHNOLOGY INCUBATOR CO., LTD. Free format text: FORMER OWNER: QINGDAO HUAREN INFORMATION TECHNOLOGY DEVELOPMENT CO., LTD. Effective date: 20140808 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Zhang Linping Inventor after: Lv Huan Inventor after: Zhang Lili Inventor before: Yang Gaolin |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: YANG GAOLIN TO: ZHANG LINPING LV HUAN ZHANG LILI |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20140808 Address after: 266071 Shandong city of Qingdao province Hongkong City Road No. 32 floor 801-A room 8 Applicant after: Qingdao Huaren Technology Incubator Co., Ltd. Address before: 266071 Shandong city of Qingdao province Hongkong City Road No. 32 (Minmetals building) 11 1101-A Applicant before: Qingdao Huaren Information Technology Development Co., Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20171023 Address after: Lang Jun Center No. 28 road 401120 Chongqing city Yubei District Huanglong longta Street Building 3 2-1 Patentee after: Chongqing AOPO Ruisen Technology Co. Ltd. Address before: 266071 Shandong city of Qingdao province Hongkong City Road No. 32 floor 801-A room 8 Patentee before: Qingdao Huaren Technology Incubator Co., Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180328 Address after: 401120 Chongqing Yubei District Hui Xing Street Xingke Road No. 293 with mountain name 7 9 Patentee after: CHONGQING XUANNU BIOTECHNOLOGY CO., LTD. Address before: Lang Jun Center No. 28 road 401120 Chongqing city Yubei District Huanglong longta Street Building 3 2-1 Patentee before: Chongqing AOPO Ruisen Technology Co. Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140903 Termination date: 20181227 |